Jan C. Oosterwijk
Jan C. Oosterwijk
Clinical Geneticist, MD, PhD
Geverifieerd e-mailadres voor umcg.nl
Geciteerd door
Geciteerd door
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
M Kriege, CTM Brekelmans, C Boetes, PE Besnard, HM Zonderland, ...
New England Journal of Medicine 351 (5), 427-437, 2004
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
Rapid detection of BRCA1 mutations by the protein truncation test
FBL Hogervorst, RS Cornelis, M Bout, M van Vliet, JC Oosterwijk, R Olmer, ...
Nature genetics 10 (2), 208, 1995
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
MM De Jong, IM Nolte, GJ Te Meerman, WTA Van der Graaf, ...
Journal of medical genetics 39 (4), 225-242, 2002
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ...
PLoS Genet 9 (3), e1003212, 2013
Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study
EM Hoogerwaard, E Bakker, PF Ippel, JC Oosterwijk, DF Majoor-Krakauer, ...
The Lancet 353 (9170), 2116-2119, 1999
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ...
European urology 66 (3), 489-499, 2014
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families
T Peelen, M Van Vliet, A Petrij-Bosch, R Mieremet, C Szabo, ...
American journal of human genetics 60 (5), 1041, 1997
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
DM van der Kolk, GH de Bock, BK Leegte, M Schaapveld, MJE Mourits, ...
Breast cancer research and treatment 124 (3), 643-651, 2010
Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy
EM Hoogerwaard, PA Van der Wouw, AAM Wilde, E Bakker, PF Ippel, ...
Neuromuscular Disorders 9 (5), 347-351, 1999
Normal phenotype in two brothers with a full FMR1 mutation
HJM Smeets, APT Smits, CE Verheij, JPG Theelen, R Willemsen, I Burgt, ...
Human molecular genetics 4 (11), 2103-2108, 1995
BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
AJ Rijnsburger, IM Obdeijn, R Kaas, MM Tilanus-Linthorst, C Boetes, ...
Inheritance of most X‐linked traits is not dominant or recessive, just X‐linked
WB Dobyns, A Filauro, BN Tomson, AS Chan, AW Ho, NT Ting, ...
American journal of medical genetics Part A 129 (2), 136-143, 2004
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ...
Nature genetics 49 (12), 1767-1778, 2017
Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
NM Van Der Velde, MJE Mourits, HJG Arts, J de Vries, BK Leegte, ...
International Journal of Cancer 124 (4), 919-923, 2009
Georg Schmorl on trophoblasts in the maternal circulation
O Lapaire, W Holzgreve, JC Oosterwijk, R Brinkhaus, DW Bianchi
Placenta 28 (1), 1-5, 2007
Novel types of mutation responsible for the dermatosparactic type of Ehlers–Danlos syndrome (type VIIC) and common polymorphisms in the ADAMTS2 gene
A Colige, L Nuytinck, I Hausser, AJ Van Essen, M Thiry, C Herens, ...
Journal of Investigative Dermatology 123 (4), 656-663, 2004
Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
MS Van Roosmalen, PFM Stalmeier, CG Verhoef, J Hoekstra-Weebers, ...
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20